Andere talen Endo International plc

Aandelen

ENDPQ

IE00BJ3V9050

Beurs gesloten - OTC Markets Andere beurzen 21:42:21 18-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,0006 ^USD	0,00%		+100,00%	+20,00%

19/03	Geneesmiddelenproducent Endo krijgt goedkeuring van Amerikaanse rechtbank voor herstructurering faillissement	RE
06/03	Endo International plc rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Endo, Inc. Announces Proposed New Senior Secured Credit Facilities	02/04
Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS	27/03
Fourth Amended Joint Reorganization Plan Approved for Endo International plc	22/03
Health Care Down on Rate Bias -- Health Care Roundup	20/03
News Highlights : Top Company News of the Day - Wednesday at 5 PM ET	20/03
Drugmaker Endo receives US court approval for bankruptcy restructuring	19/03
Drugmaker Endo receives US court approval for bankruptcy restructuring, Bloomberg News reports	19/03
Fourth Amended Joint Reorganization Plan Filed by Endo International plc	18/03
Par Pharmaceutical Issues Voluntary Nationwide Recall of One Lot of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution	12/03
North American Morning Briefing : Stock Futures -2-	11/03
Health Care Flat After Trial Setbacks -- Health Care Roundup	08/03
Endo International plc Reports Earnings Results for the Full Year Ended December 31, 2023	06/03
Endo International plc Reports Property, Plant and Equipment Impairment Charges for the Three Months Ended December 31, 2023	06/03
Endo International plc Provides Earnings Guidance for the Year 2024	06/03
Endo International plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	06/03
ENDO REPORTS FOURTH-QUARTER 2023 FINANCIAL RESULTS	06/03
Endo va payer 2 milliards de dollars à cause d'un traitement opiacé	29/02
Drugmaker Endo reaches $465 mln bankruptcy settlement with US	29/02
Endo Reaches Resolution with U.S. Department of Justice Regarding Legacy Marketing of Opana® ER	29/02
Third Amended Joint Reorganization Plan and Disclosure Statement Filed by Endo International plc	20/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Endo International plc

Aandelen

ENDPQ

IE00BJ3V9050

Andere talen

Filters